The coronavirus disease (COVID-19) pandemic has posed a major challenge to medical services worldwide. The causative agent-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-is a virus mainly transmitted via droplets and contact; however, data are emerging that support airborne transmission during aerosol-generating procedures, including endoscopy. Since almost 50% of COVID-19 patients exhibit detectable viral RNA in fecal samples, 1,2 there are still considerable concerns regarding viral transmission within endoscopic units, forcing endoscopists to implement strict precautions, such as a high threshold for endoscopy. 3 Indeed, the pandemic has had a significant global impact on endoscopic services, which is linked to the substantial reduction in capacity. 4 Using the UK National Endoscopy Database, Rutter et al. 5 analyzed the impact of the COVID-19 pandemic on endoscopic services, reporting that activity during the COVID-affected period had reduced to 12% of the pre-COVID level, and only 5% during the lowest period. Conversely, a recent detailed nominal analysis of the pandemic's impact on nonurgent endoscopic treatments-including peroral endoscopic myotomy (POEM)-may be informative and facilitate preparation for the upcoming resurge.Ominami et al. 6 analyzed the impact of COVID-19 on high-resolution manometry (HRM) and POEM for esophageal motility disorders (EMDs), including achalasia. The study was conducted across 14 Japanese high-volume centers with expertise in POEM, using a questionnaire survey. Since POEM should be specialized, intensified, and personalized due to the orphan entities of EMDs, the procedure is not widely distributed-even with Japanese precedence-and can only be performed at a limited number of facilities; cross-regional referrals have therefore been considerably frequent. They therefore confirmed for the first time that compared with 2019-just before the COVID-19 pandemic-HRM and POEM decreased by 17.2% (1587 to